| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,392 | 0,520 | 01.06. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.04. | ORBUSNEICH (06929): REMINDER LETTER TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT AND CIRCULAR INCLUDING NOTICE OF ANNUAL ... | 1 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): REMINDER LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR INCLUDING NOTICE OF ANNUAL GENERAL ... | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 8, 2026 | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, (3) ... | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | 2 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): ANNUAL REPORT 2025 | 2 | HKEx | ||
| 12.03. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Achieves Record-breaking Revenue, Sales Volume and Gross Profit in FY2025, Net Profit Rises to US$42 million, Final Dividend Increases by 20% to HK12 Cents per Share | 658 | JCN Newswire | - Sharpens Competitive Edge in Commercialization and Product Innovation- While Exploring New Business Models for Sustainable GrowthHONG KONG, Mar 12, 2026 - (ACN Newswire) - Results Highlights:- Revenue... ► Artikel lesen | |
| ORBUSNEICH MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
| 12.03. | OrbusNeich Medical Group Holdings Limited Full Year Income Advances | 2 | RTTNews | ||
| 12.03. | ORBUSNEICH (06929): FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2025 | 1 | HKEx | ||
| 12.03. | ORBUSNEICH (06929): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 AND CHANGE IN USE OF PROCEEDS | 2 | HKEx | ||
| 02.03. | ORBUSNEICH (06929): DATE OF BOARD MEETING | 1 | HKEx | ||
| 22.01. | ORBUSNEICH (06929): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 22.01. | ORBUSNEICH (06929): RESIGNATION OF NON-EXECUTIVE DIRECTOR | 2 | HKEx | ||
| 18.09.25 | Dividendenbekanntmachungen (18.09.2025) | 11.359 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,115 NZD 0,058 EUR APLICACIONES Y TRATAMIENTO DE SISTEMAS S ... ES0105691002 - 0,0201 EUR AXFOOD... ► Artikel lesen | |
| 15.08.25 | OrbusNeich Medical Group Holdings Limited: OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively | 721 | JCN Newswire | - Declares Special Dividend of HK15 Cents per Share to Celebrate 25th Anniversary- Leveraging Strategic Global Footprint and Innovative Products to Navigate Macroeconomic Challenges and Capture Strong... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 35,450 | -2,26 % | dpa-AFX-Überblick: UNTERNEHMEN vom 26.05.2026 - 15.15 Uhr | Schwerwiegende Bedenken: BP trennt sich von Verwaltungsratschef - Kursrutsch LONDON - Der britische Ölkonzern BP setzt seinen Verwaltungsratschef Albert Manifold wegen Vorwürfen vor die Tür. Als... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,400 | -2,12 % | FMC startet Aktienrückkauf über eine Milliarde Euro | Die Fresenius Medical Care AG hat ein Aktienrückkaufprogramm mit einem Gesamtvolumen von rund einer Milliarde Euro beschlossen, das innerhalb von zwölf Monaten in Tranchen umgesetzt werden soll. Grundlage... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,260 | -1,89 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU)... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,290 | -0,08 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,00 | +0,03 % | BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable | ||
| GENEDX | 52,00 | 0,00 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| QTREX QUANTUM | 3,100 | +0,65 % | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | ||
| BILLIONTOONE | 90,86 | -0,29 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,860 | 0,00 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| PROGYNY | 26,210 | +0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| HEARTFLOW | 30,950 | -0,16 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,020 | +0,54 % | EQS-DD: Carl Zeiss Meditec AG: Peter Kameritsch, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.05.2026 / 14:57... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 9,665 | 0,00 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| ADAPTHEALTH | 9,910 | -0,20 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| PRIVIA HEALTH GROUP | 21,300 | -0,05 % | Privia Health Group, Inc.: Privia Health Enters New Jersey |